Kit formulation of active pharmaceutical ingredient d,l-HMPAO as a brain perfusion diagnostic system
1. Kit formulation of active pharmaceutical ingredient d,l-HMPAO as a brain perfusion diagnostic system

Mohammadreza Davarpanah; Hossein Abbasi; Mehdi Nabati; Hamideh Sabahnoo; Vida Bodaghi-Namileh; Mohammad Mazidi; Hossein Movahhed-Tazehkand; Hossein Mohammadnejad-Mehrabani

Volume 2, Issue 4 , Autumn 2019, , Pages 185-191

http://dx.doi.org/10.33945/SAMI/PCBR.2019.4.4

Abstract
  The purpose of this research study is to prepare Exametazime (d,l-HMPAO) kit for labeling with 99m-technetium radionuclide as a brain perfusion diagnostic system. In first step, the ...  Read More
Molecular Modeling of the antagonist compound esketamine and its molecular docking study with non-competitive N-methyl-D-aspartate (NMDA) receptors NR1, NR2A, NR2B and NR2D
2. Molecular Modeling of the antagonist compound esketamine and its molecular docking study with non-competitive N-methyl-D-aspartate (NMDA) receptors NR1, NR2A, NR2B and NR2D

Mehdi Nabati; Vida Bodaghi-Namileh; Saman Sarshar

Volume 2, Issue 3 , Summer 2019, , Pages 108-119

http://dx.doi.org/10.33945/SAMI/PCBR.2019.2.4

Abstract
  The main purpose of the present article is reactivity and stability properties study of the antagonist compound esketamine and analyzing of its binding to the non-competitive N-methyl-D-aspartate ...  Read More